Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated SARS-CoV-2 Vaccine in Healthy Adults in Peru
NCT04612972Phase 3Completed
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Sep 2020
- Primary completion
- Feb 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated SARS-CoV-2 vaccine (WIBP), BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Universidad Peruana Cayetano Heredia. Started Sep 2020; status: completed.
02
Drugs
inactivated SARS-CoV-2 vaccine (WIBP)BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04612972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04612972.